Validation of Innovative Scheimpflug Topography Derived RGP Contact Lens Designs In Optometry Network (VISION)

Moorfields Eye Hospital NHS Foundation Trust

Status: Completed

Conditions: Keratoconus

Treatments: Device: The contact lens to be investigated in this study (Scheimpflug topography derived corneal RGP contact lens design). A CE (UKCA) marked class 2 medical devices.

Study type: Observational

Funder types: Other

Identifiers

NCT06312163

EHRD1001

Details and patient eligibility

About

The goal of this Prospective, single-site, cohort study is to validate rigid gas permeable corneal contact lens (RGP) designs for keratoconus derived from combining the data from corneal topography scans and contact lenses ordered in patients with keratoconus (KC) attending a UK tertiary NHS Hospital contact lens clinic. The main questions it aims to answer are:

• Does a Scheimpflug topography derived RGP contact lens design for keratoconus have the equivalent overall contact lens fit as the patients' own lens?
• Is the number of trial lenses required to fit a patient is reduced compared to standard practice?
• Is the time taken to fit a contact lens is reduced compared to standard practice?
• Is there user acceptance of the new lens?
• Are the Axial ege lift (AEL) changes clinically significant?

There will be 3 work packages

WP1: For each participant data collection will take place over two visits.

• Visit 1: Pentacam topography scans and optimal 'virtual' lens selection will take place. • • Visit 2: Participants are fitted with 4 contact lenses (i) the optimal lens design as specified by the virtual fitting module, (ii) a contact lens with a clinically significant step flatter AEL (iii) a contact lens steeper in axial edge lift (AEL) (iv) the participant's own contact lens.

Each CL fit will be assessed with slit lamp photography according to the standardised method proposed by Wolffsohn et al. (2013), Anterior segment OCT MS39) (CSO Hansom Instruments, UK) and best-corrected visual acuity with each lens design using high-contrast logMAR .

WP2. Participants will attend one appointment where a traditional lens fit, and a lens fitted using the topography guided 'virtual' module will be undertaken (with the fitting method selected for each eye randomised). For each fitting method the total fitting time will be measured and the total number of trial contact lenses used. Patients will be invited to complete a questionnaire that probes their satisfaction of this process.

WP3. Clinicians not involved in the study will be invited to examine a demo version of the virtual fitting module and complete the validated system usability scale tool.

Enrollment: 120 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• • WP1:
• (a) Presence of keratoconus in either eye
• (b) Currently using a rigid gas permeable contact lens correction
• (c) Male or female, aged 18 years or older
• (d) The absence of significant media opacities
• (e) No ocular pathology other than keratoconus
• (f) Ability to understand nature/purpose of the study and to provide informed consent
• (g) Ability to follow instructions and complete the study
• (h) Ability to speak English
• WP2:
• (a) Presence of keratoconus in both eyes
• (b) Male or female, aged 18 years or older
• (c) The absence of significant media opacities
• (d) No ocular pathology other than keratoconus
• (e) Ability to understand nature/purpose of the study and to provide informed consent
• (f) Ability to follow instructions and complete the study
• (g) Ability to speak English
• WP3:
• (a) Optometrist, dispensing optician or ophthalmologist registered with the General Optical Council
• (b) Works within contact lens service at Moorfields Eye Hospital
• (c) Ability to understand nature/purpose of the study and to provide informed consent
• (d) Ability to follow instructions and complete the study
• (e) Ability to speak English .

Exclusion criteria

• • WP1:
• (a) Any systemic disease likely to affect visual performance
• (b) Any ocular disease that may affect visual performance, other than keratoconus
• (c) Hearing impairment sufficient to interfere with hearing instructions
• (d) Poor understanding of English language and/or alphabet
• (e) Any condition which, in the investigator's opinion, would conflict or otherwise prevent the participant from
• complying with the required procedures, schedule, or other study conduct.
• (f) Not currently using a rigid gas permeable contact lens or a contraindication to this
• (g) A history of corneal graft surgery (keratoplasty) in the eye under investigation.
• (h) A recent history (in preceding 12 months) of corneal abrasions in the designated study eye
• (i) A recent history (in preceding 1 month) of corneal cross linking for keratoconus
• WP2:
• (a) Any systemic disease likely to affect visual performance
• (b) Any ocular disease that may affect visual performance, other than keratoconus
• (c) Hearing impairment sufficient to interfere with hearing instructions
• (d) Poor understanding of English language and/or alphabet
• (e) Any condition which, in the investigator's opinion, would conflict or otherwise prevent the participant from
• complying with the required procedures, schedule, or other study conduct.
• (f) A contraindication to rigid gas permeable contact lens wear
• (g) A history of corneal graft surgery (keratoplasty) in the eye under investigation.
• (h) A recent history (in preceding 12 months) of corneal abrasions in the either eye
• (i) A recent history (in preceding 1 month) of corneal cross linking for keratoconus
• WP3:
• (a) An optometrist dispensing optician or ophthalmologist not fully registered with the General Optical Council (e.g., a pre-registration optometrist)
• (b) Hearing impairment sufficient to interfere with hearing instructions
• (c) Poor understanding of English language and/or alphabet
• (d) Any condition which, in the investigator's opinion, would conflict or otherwise prevent the participant from complying with the required procedures, schedule, or other study conduct.

Trial design

120 participants in 2 patient groups

ARM1

Description:

The contact lens to be investigated in this study (Scheimpflug topography derived corneal RGP contact lens design)

Treatment:

Device: The contact lens to be investigated in this study (Scheimpflug topography derived corneal RGP contact lens design). A CE (UKCA) marked class 2 medical devices.

Arm2

Description:

The patient's own corneal RGP lens - CE (UKCA) marked class 2 medical devices.

Treatment:

Device: The contact lens to be investigated in this study (Scheimpflug topography derived corneal RGP contact lens design). A CE (UKCA) marked class 2 medical devices.